Indivior Pharmaceuticals (INDV) said Thursday it plans a $400 million private offering of convertible senior unsecured notes due March 15, 2031.
The company expects to grant the initial purchasers a 30-day option to buy up to an additional $60 million of the notes.
Indivior said it plans to use the net proceeds to help repay borrowings under and terminate the note purchase agreement that governs its term loan and revolving credit facility, among other things.
The company's shares were down 5.3% in premarket activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments